Skip to content

Multicenter, interventional prospective study to evaluate the efficiency of pre- and postoperative margin assessment of basal cell carcinomas using optical coherence tomography and line-field confocal optical coherence tomography during micrographically controlled surgery

Multicenter, interventional prospective study to evaluate the efficiency of pre- and postoperative margin assessment of basal cell carcinomas using optical coherence tomography and line-field confocal optical coherence tomography during micrographically controlled surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037905
Enrollment
290
Registered
2025-09-12
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44

Interventions

Group 1: Intervention group (LC-OCT): Preoperative tumor margin assessment using LC-OCT with targeted extension of the resection margins in case of tumor detection on imaging. Group 2: Control group (

Sponsors

Universitätsklinikum Augsburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults (=18 years) with BCC scheduled for MMS, confirmed by dermoscopy and histopathology or OCT. There are no restrictions regarding tumor size or BCC subtypes.

Exclusion criteria

Exclusion criteria: Poor LC-OCT image quality, incomplete adherence to the protocol, prior treatment of BCC. Anatomically difficult locations for LC-OCT are to be excluded (e.g., inner ear, medial canthus of the eye).

Design outcomes

Primary

MeasureTime frame
The endpoint is the proportion of basal cell carcinomas (BCC) that were completely (R0) removed during the first surgical excision without the need for an additional MMS cycle. This is assessed on the day of surgery or the following day through histopathological examination of the initial excision specimen. This should be measured by: - the number of MMS cycles required (compared to conventional procedures), - the probability of complete tumour removal (R0) in the first incision.

Secondary

MeasureTime frame
Total duration of the surgical procedure Definition: Time in minutes from the first skin incision to the complete completion of tumor removal (last MMS cycle). Measurement time point: On the day of surgery (intraoperative). Unit: Minutes. Number of required MMS cycles Definition: Total number of excision rounds needed to ensure all tumor margins were histologically tumor-free. Measurement time point: On the day of surgery. Unit: Number (1, 2, 3, …). Size of the final skin defect Definition: Area of the surgical defect after complete tumor removal. Measurement time point: After the last excision, before wound closure. Unit: cm². Cosmetic outcome (POSAS score) Definition: Patient and Observer Scar Assessment Scale (POSAS), assessed 6–12 weeks postoperatively. Measurement time point: At follow-up visit 2 (week 6–12). Unit: Scale value (1–10 per subcategory; lower = better). Patient satisfaction Definition: Subjective evaluation of treatment by the participant (e.g., via Likert scale). Measurement time point: Week 6–12. Unit: 5- or 7-point scale. Correlation of LC-OCT margin findings with histopathological results Definition: Sensitivity, specificity, positive predictive value, and negative predictive value of LC-OCT for detecting tumor-positive margins. Measurement time point: After availability of histological results. Unit: Percent agreement. Occurrence of adverse events Definition: Any medically relevant complication related to imaging or surgery (e.g., wound infection, postoperative bleeding). Measurement time point: Until completion of the second follow-up visit. Unit: Number of events per patient group.

Countries

Germany

Contacts

Public ContactJulia Welzel

Universitätsklinikum Augsburg

julia.welzel@uk-augsburg.de+498214007401

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026